Tirzepatide 50mg
High-Potency Dual GIP & GLP-1 Receptor Agonist
$145.00$125.00
Grade: Research Grade / Analytical Standard
Purity: ≥99% (HPLC Verified)
Format: Lyophilized (Freeze-Dried) Powder
Unit Size: 50 mg
Product Overview
Tirzepatide 50mg represents a bulk high-potency format engineered for extensive laboratory research, high-throughput assays, and long-term experimental series into dual incretin signaling. As a synthetic dual GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptor agonist, Tirzepatide activates two distinct metabolic pathways simultaneously to deliver synergistic physiological effects.
This high-capacity 50mg unit is optimized for research facilities, institutions, and core laboratories requiring substantial compound volumes for multi-subject or extended-duration trial protocols.
Key Research Features & Highlights
High-Volume 50mg Capacity: Maximizes research efficiency and cost-effectiveness by providing ample material for multi-run assays, batch testing, and long-term protocols.
Dual-Receptor Agonism: Simultaneously targets GIP and GLP-1 receptors, enabling deep investigation into pathway synergy and cellular cross-talk.
C20 Fatty Acid Modification: Incorporates a specialized diacyl chain to extend half-life and enhance stability during analytical procedures.
Analytical Purity (≥99%): Strictly batch-tested via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to maintain standard accuracy and reproducibility.
Primary Applications in Laboratory Research
Synergistic Incretin Kinetics: Researching the combined biological impact of dual GIP/GLP-1 pathway stimulation versus single-agonist activity.
Extended Metabolic Studies: Analyzing long-term impacts on glucose regulation, lipid metabolism, and cellular energy expenditure.
CNS & Appetite Mechanics: Mapping hypothalamic pathways involved in satiety control, food reward pathways, and gastric motility.
High-Throughput Comparative Screening: Benchmarking dual-agonist efficiency against mono-agonists (e.g., Semaglutide) and triple-agonists (e.g., Retatrutide).
Product Specifications
Attribute | Specification |
Active Compound | Tirzepatide (LY3298176) |
Net Quantity | 50 mg |
Form | Lyophilized White Powder |
CAS Number | 2023788-19-2 |
Molecular Mass | ~4813.45 g/mol |
Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
Purity Standard | ≥99% (HPLC verified) |
Solubility | Soluble in Bacteriostatic Water or Sterile Deionized Water |
Storage & Handling Protocols
Unreconstituted (Lyophilized): Keep stored at or below -20°C in a dark, dry environment protected from light exposure and moisture.
Reconstituted Solution: Once reconstituted with a sterile solvent (e.g., Bacteriostatic Water), keep refrigerated at 2°C – 8°C and utilize within 30 days. Avoid repeated freeze-thaw cycles.
Mandatory Research & Legal Disclaimer
FOR LABORATORY RESEARCH USE ONLY. This compound is distributed strictly for in vitro scientific, educational, and analytical laboratory applications. It is not approved for human or animal consumption, medical treatment, diagnostic procedures, or commercial drug formulation.